ResearcherTongji UniversityActive in the last 2 years

Xiao Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8652-8820; OpenAlex author ID A5100411498. Sources: OpenAlex.

Their work

Papers: 4 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through the FAK/AKT/Mtor-gpx4 cascade. First author DOI 10.1016/j.redox.2025.103721 ↗
Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells. Co-author DOI 10.1016/j.ejphar.2020.173840 ↗
FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes. Co-author DOI 10.7150/ijbs.56733 ↗
(3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells. First author DOI 10.1016/j.bioorg.2020.104022 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zongting Gu · 1 shared paper, 2025 · strength 0.28
- Paper TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through t… DOI 10.1016/j.redox.2025.103721 ↗
Ran Tao · 1 shared paper, 2025 · strength 0.28
- Paper TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through t… DOI 10.1016/j.redox.2025.103721 ↗
Peng Nan · 1 shared paper, 2025 · strength 0.28
- Paper TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through t… DOI 10.1016/j.redox.2025.103721 ↗
Xuetao Xu · 2 shared papers, 2020–2021 · strength 0.22
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840 ↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022 ↗
Kun Zhang · 2 shared papers, 2020–2021 · strength 0.22
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840 ↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022 ↗
Xi Zheng · 2 shared papers, 2020–2021 · strength 0.22
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840 ↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022 ↗
Yong Gao · 1 shared paper, 2021 · strength 0.16
- Paper FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor ge… DOI 10.7150/ijbs.56733 ↗
Dongli Li · 1 shared paper, 2020 · strength 0.10
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022 ↗
Panpan Wu · 1 shared paper, 2020 · strength 0.10
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.